These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 18063077)
1. Good blood pressure control on antihypertensives, not only response to spironolactone, predicts improved outcome after adrenalectomy for aldosteronoma. Zarnegar R; Lee J; Brunaud L; Lindsay S; Kebebew E; Clark OH; Duh QY Surgery; 2007 Dec; 142(6):921-9; discussion 921-9. PubMed ID: 18063077 [TBL] [Abstract][Full Text] [Related]
2. Normokalemic hyperaldosteronism in patients with resistant hypertension. Benchetrit S; Bernheim J; Podjarny E Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302 [TBL] [Abstract][Full Text] [Related]
3. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone? Mahmud A; Mahgoub M; Hall M; Feely J Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838 [TBL] [Abstract][Full Text] [Related]
4. The aldosteronoma resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma. Zarnegar R; Young WF; Lee J; Sweet MP; Kebebew E; Farley DR; Thompson GB; Grant CS; Clark OH; Duh QY Ann Surg; 2008 Mar; 247(3):511-8. PubMed ID: 18376197 [TBL] [Abstract][Full Text] [Related]
5. Urinary aldosterone-to-active-renin ratio: a useful tool for predicting resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenomas. Mourad JJ; Girerd X; Milliez P; Lopez-Sublet M; Lejeune S; Safar ME Am J Hypertens; 2008 Jul; 21(7):742-7. PubMed ID: 18443567 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of add-on aldosterone receptor blocker in uncontrolled hypertension. Sharabi Y; Adler E; Shamis A; Nussinovitch N; Markovitz A; Grossman E Am J Hypertens; 2006 Jul; 19(7):750-5. PubMed ID: 16814132 [TBL] [Abstract][Full Text] [Related]
7. Outcomes of laparoscopic adrenalectomy for hyperaldosteronism. Pang TC; Bambach C; Monaghan JC; Sidhu SB; Bune A; Delbridge LW; Sywak MS ANZ J Surg; 2007 Sep; 77(9):768-73. PubMed ID: 17685956 [TBL] [Abstract][Full Text] [Related]
8. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas. Rossi E; Sani C; Perazzoli F; Casoli MC; Negro A; Dotti C Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003 [TBL] [Abstract][Full Text] [Related]
9. Primary hyperaldosteronism in the era of laparoscopic adrenalectomy. Rossi H; Kim A; Prinz RA Am Surg; 2002 Mar; 68(3):253-6; discussion 256-7. PubMed ID: 11893103 [TBL] [Abstract][Full Text] [Related]
10. Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma. Letavernier E; Peyrard S; Amar L; Zinzindohoué F; Fiquet B; Plouin PF J Hypertens; 2008 Sep; 26(9):1816-23. PubMed ID: 18698217 [TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism. Sywak M; Pasieka JL Br J Surg; 2002 Dec; 89(12):1587-93. PubMed ID: 12445071 [TBL] [Abstract][Full Text] [Related]
13. Surgical outcomes following laparoscopic adrenalectomy for treatment of Conn's syndrome (primary hyperaldosteronism) between 1999 and 2006. Herd A; Harman R; Taylor E N Z Med J; 2010 Oct; 123(1324):50-6. PubMed ID: 20953222 [TBL] [Abstract][Full Text] [Related]
14. Characteristics predicting clinical improvement and cure following laparoscopic adrenalectomy for primary aldosteronism in a large cohort. Worth PJ; Kunio NR; Siegfried I; Sheppard BC; Gilbert EW Am J Surg; 2015 Oct; 210(4):702-9. PubMed ID: 26323999 [TBL] [Abstract][Full Text] [Related]
15. Ventricular repolarization before and after treatment in patients with secondary hypertension due to renal-artery stenosis and primary aldosteronism. Maule S; Bertello C; Rabbia F; Milan A; Mulatero P; Milazzo V; Papotti G; Veglio F Hypertens Res; 2011 Oct; 34(10):1078-81. PubMed ID: 21677661 [TBL] [Abstract][Full Text] [Related]
16. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study. Giacchetti G; Ronconi V; Turchi F; Agostinelli L; Mantero F; Rilli S; Boscaro M J Hypertens; 2007 Jan; 25(1):177-86. PubMed ID: 17143190 [TBL] [Abstract][Full Text] [Related]
17. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Catena C; Colussi G; Nadalini E; Chiuch A; Baroselli S; Lapenna R; Sechi LA Arch Intern Med; 2008 Jan; 168(1):80-5. PubMed ID: 18195199 [TBL] [Abstract][Full Text] [Related]
18. Long-term effects of adrenalectomy or spironolactone on blood pressure control and regression of left ventricle hypertrophy in patients with primary aldosteronism. Indra T; Holaj R; Štrauch B; Rosa J; Petrák O; Šomlóová Z; Widimský J J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1109-17. PubMed ID: 25271250 [TBL] [Abstract][Full Text] [Related]
19. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio. Hood SJ; Taylor KP; Ashby MJ; Brown MJ Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839 [TBL] [Abstract][Full Text] [Related]